MedPath

DreamTec Research Limited

🇭🇰Hong Kong, China
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:3

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

COVID19 Oral Vaccine Consisting of Bacillus Subtilis Spores

Not Applicable
Completed
Conditions
COVID-19 Pneumonia
First Posted Date
2022-02-15
Last Posted Date
2022-02-15
Lead Sponsor
DreamTec Research Limited
Target Recruit Count
35
Registration Number
NCT05239923
Locations
🇭🇰

DreamTec Research Limited, Hong Kong, Hong Kong

🇮🇷

Middle East Cell and Gene Therapy, Tehran, Iran, Islamic Republic of

Oral Neutralizing Antibody Booster for Post-vaccinated People With COVID19 Vaccine

Not Applicable
Completed
Conditions
COVID-19 Pandemic
First Posted Date
2021-12-15
Last Posted Date
2022-06-30
Lead Sponsor
DreamTec Research Limited
Target Recruit Count
16
Registration Number
NCT05158855
Locations
🇲🇴

Macao Greater Bay Area Association of Healthcare Providers, Macau, Macau

The Development of a COVID19 Oral Vaccine Consisting of Bacillus Subtilis Spores

Not Applicable
Completed
Conditions
COVID-19 Pneumonia
First Posted Date
2021-09-27
Last Posted Date
2023-05-31
Lead Sponsor
DreamTec Research Limited
Target Recruit Count
9
Registration Number
NCT05057923
Locations
🇭🇰

Zentrogene Bioscience Laboratory Ltd, Hong Kong, Hong Kong

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.